-
Product Insights
NewAesthetic Injectables Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Aesthetic Injectables Pipeline Market Report Overview Aesthetic injectables are gel-like substances injected beneath the skin to restore a youthful appearance by increasing the volume of sunken cheeks or temples or reducing lines around the nose and mouth, among other processes. Aesthetic Injectables are grouped into segments based on their molecular composition. The aesthetic injectables pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PB-718 in Obesity
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. PB-718 in Obesity Drug Details: PB-718 is under development for the treatment of nonalcoholic fatty...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – PB-357 in Breast Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PB-357 in Breast Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.PB-357 in Breast CancerDrug Details:PB-357 is under development for the treatment of breast...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PB-718 in Type 2 Diabetes
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PB-718 in Type 2 Diabetes report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.PB-718 in Type 2 Diabetes Drug Details:PB-718 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PB-718 in Non-Alcoholic Steatohepatitis (NASH)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PB-718 in Non-Alcoholic Steatohepatitis (NASH) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.PB-718 in Non-Alcoholic Steatohepatitis (NASH)Drug Details:PB-718 is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Surufatinib in Peritoneal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Surufatinib in Peritoneal Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Surufatinib in Peritoneal Cancer Drug Details: Surufatinib (Sulanda) is a potential...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Bimekizumab in Ankylosing Spondylitis (Bekhterev’s Disease)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Bimekizumab in Ankylosing Spondylitis (Bekhterev's Disease) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Bimekizumab in Ankylosing Spondylitis (Bekhterev's Disease) Drug Details: Bimekizumab...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PB-718 in Non Alcoholic Fatty Liver Disease (NAFLD)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PB-718 in Non Alcoholic Fatty Liver Disease (NAFLD) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.PB-718 in Non Alcoholic Fatty Liver Disease (NAFLD)Drug Details:PB-718...